These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2908034)

  • 1. Clinical experience with a radioreceptor assay for TSH-binding inhibiting immunoglobulins (TBII).
    Heberling HJ; Bierwolf B; Lohmann D
    Exp Clin Endocrinol; 1988 Aug; 91(3):355-61. PubMed ID: 2908034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical value of the determination of TSH-binding inhibitory immunoglobulins (TBII) by a radioreceptor assay].
    Heberling HJ; Bierwolf B; Lohmann D
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(5):301-6. PubMed ID: 2879721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical relevance of the determination of TSH-binding inhibitory immunoglobulins (TBII) in patients with immunogenic hyperthyroidism in methimazole therapy].
    Heberling HJ; Bierwolf B; Kuhlmann E; Klugmann T; Dietel P; Fischer S
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(6):331-6. PubMed ID: 2896115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of thyrotropin binding inhibiting immunoglobulins (TBII) assay in hyperthyroidism.
    Duron F; Talbot JN; Féron R; Aubert P; Milhaud G
    Biomed Pharmacother; 1987; 41(7):383-8. PubMed ID: 2895672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin binding inhibiting immunoglobulins (TBII) in Graves' disease, toxic nodular goitre and autoimmune thyroiditis.
    Wägar G; Mäkinen T; Lamberg BA; Gordin A; Apter L; Pekonen F
    Ann Clin Res; 1982 Apr; 14(2):83-9. PubMed ID: 6184007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.
    Morris JC; Hay ID; Nelson RE; Jiang NS
    Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detectability of thyroid anti-microsomal antibodies, changes in thyroid-stimulating immunoglobulins (TSI) and thyrotropin-binding-inhibiting immunoglobulins (TBII) during methimazole treatment of Graves' disease patients.
    Szabó J; Leövey A; Karányi Z; Várvölgyi C; Fórizs E; Herceg L
    Acta Med Hung; 1989; 46(1):23-30. PubMed ID: 2570399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of thyroid stimulating antibodies and TSH-binding inhibiting immunoglobulins in the follow-up of Graves' disease.
    Hörmann R; Saller B; Müller R; Mann K
    Klin Wochenschr; 1985 Dec; 63(24):1247-52. PubMed ID: 2868149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
    Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
    Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous assay for three types of thyrotropin receptor antibody activities using FRTL-5 cells in patients with autoimmune thyroid diseases.
    Zhu Y; Portmann L; Dénéréaz N; Lemarchand-Béraud T
    Eur J Endocrinol; 1994 Oct; 131(4):359-68. PubMed ID: 7921224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioreceptor assay of anti-TSH receptor antibody activity: comparison of assays using unextracted serum and immunoglobulin fractions, and standardization of expression of activities.
    Tamaki H; Amino N; Watanabe Y; Aozasa M; Hayashi H; Tachi J; Miyai K
    J Clin Lab Immunol; 1986 May; 20(1):1-6. PubMed ID: 3016274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum thyrotropin binding inhibitory immunoglobulin (TBII) activity before and after subtotal thyroidectomy in Grave's disease].
    Hoshi T; Watanabe I; Endo S
    Nihon Geka Gakkai Zasshi; 1985 Nov; 86(11):1538-45. PubMed ID: 2867461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of TSH-binding inhibiting immunoglobulins in patients with Graves' disease and non toxic goiter.
    Mossetti G; Salomone Megna A; Lanzano C; Maddaloni D; Leonello D; Gravina E
    Boll Ist Sieroter Milan; 1986; 65(4):277-82. PubMed ID: 2878674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study.
    Vos XG; Smit N; Endert E; Tijssen JG; Wiersinga WM
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):311-7. PubMed ID: 18208575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
    Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
    J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical role of TSH binding inhibiting antibodies (TBIAb) assay.
    Rubello D; Girelli ME; Piccolo M; Franzelin F; Betterle C; Busnardo B
    J Nucl Med Allied Sci; 1990; 34(1):29-33. PubMed ID: 2384822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotrophin binding inhibiting immunoglobulins in Graves' disease before, during and after antithyroid therapy, and its relation to long-acting thyroid stimulator.
    Docter R; Bos G; Visser TJ; Hennemann G
    Clin Endocrinol (Oxf); 1980 Feb; 12(2):143-53. PubMed ID: 6105023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of tsh binding inhibiting antibodies (TBI-ab) and thyroid adenylate cyclase stimulating antibodies (TS-ab) in sera of patients with Graves' disease.
    Lattanzi V; Scardapane R; Ciampolillo A; Vincenti C; Giorgino R
    Boll Soc Ital Biol Sper; 1985 Jan; 61(1):55-60. PubMed ID: 3838478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.